EXCLUSIVE. According to the Nobel Prize-winning economist, Europe needs to review its innovation policy, or it will disappear ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, or semaglutide, has been approved for the treatment of patients ...

A/S, a global healthcare giant specializing in diabetes care and obesity treatment, continues to dominate the GLP-1 drug market alongside competitor Eli Lilly (NYSE:LLY). With a market capitalization ...

Novo Nordisk shares were 9.5% higher after the pharmaceutical giant said an experimental weight-loss shot showed patients ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Good news about an experimental weight-loss shot sent shares in Ozempic maker Novo Nordisk soaring, making it once again Europe's most-valuable listed company. A pullback in the Danish drug maker's ...

Novo Nordisk was slammed by a U.K. trade group for not disclosing payments to health and patient groups, according to a draft ...

The broadness and innovative strength keep Swedish life science exports strong, but the protectionist tendencies in the world ...

Novo Nordisk vil ikke sige, hvor den får sine forsøgsaber fra. Så vi fandt dem selv på en farm i Vietnam med tråde til det ...

Novo Nordisk vil ikke sige, hvor virksomheden får sine forsøgsaber fra. Så vi fandt dem selv på en farm i Vietnam med tråde ...

Vietnam's Prime Minister Pham Minh Chinh (R) and Russia's Prime Minister Mikhail Mishustin (L) shake hands during a signing ceremony at the Government Office in Hanoi on January 14, 2025. (Photo by ...